Life Science REIT PLC (LSE:LABS) — Market Cap & Net Worth
Market Cap & Net Worth: Life Science REIT PLC (LABS)
Life Science REIT PLC (LSE:LABS) has a market capitalization of $1.84 Million (GBX15.09 Billion) as of May 2, 2026. Listed on the LSE stock exchange, this UK-based company holds position #29765 globally and #693 in its home market, demonstrating a 3.36% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Life Science REIT PLC's stock price GBX43.10 by its total outstanding shares 350000000 (350.00 Million). Analyse LABS cash flow conversion to see how efficiently the company converts income to cash.
Life Science REIT PLC Market Cap History: 2021 to 2026
Life Science REIT PLC's market capitalization history from 2021 to 2026. Data shows change from $3.84 Million to $1.84 Million (-15.24% CAGR).
Index Memberships
Life Science REIT PLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE All-Share
FTAS
|
$62.11 Billion | 0.00% | #450 of 573 |
Weight: Life Science REIT PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Life Science REIT PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Life Science REIT PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
Life Science REIT PLC's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $3.84 Million | $8.12 Million | $7.74 Million | 0.47x | 0.50x |
| 2022 | $2.74 Million | $-19.92 Million | -$27.61 Million | -0.14x | N/A |
| 2023 | $2.55 Million | $19.94 Million | -$21.71 Million | 0.13x | N/A |
| 2024 | $1.62 Million | $20.31 Million | -$13.98 Million | 0.08x | N/A |
Competitor Companies of LABS by Market Capitalization
Companies near Life Science REIT PLC in the global market cap rankings as of May 2, 2026.
Key companies related to Life Science REIT PLC by market ranking:
- Welltower Inc (NYSE:WELL): Ranked #154 globally with a market cap of $146.77 Billion USD.
- Ventas Inc (NYSE:VTR): Ranked #653 globally with a market cap of $40.60 Billion USD.
- Omega Healthcare Investors Inc (NYSE:OHI): Ranked #1717 globally with a market cap of $13.89 Billion USD.
- Healthpeak Properties Inc (NYSE:DOC): Ranked #2019 globally with a market cap of $11.41 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #154 | Welltower Inc | NYSE:WELL | $146.77 Billion | $216.91 |
| #653 | Ventas Inc | NYSE:VTR | $40.60 Billion | $88.02 |
| #1717 | Omega Healthcare Investors Inc | NYSE:OHI | $13.89 Billion | $46.98 |
| #2019 | Healthpeak Properties Inc | NYSE:DOC | $11.41 Billion | $16.42 |
Life Science REIT PLC Historical Marketcap From 2021 to 2026
Between 2021 and today, Life Science REIT PLC's market cap moved from $3.84 Million to $ 1.84 Million, with a yearly change of -15.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX1.84 Million | +9.39% |
| 2025 | GBX1.68 Million | +3.68% |
| 2024 | GBX1.62 Million | -36.66% |
| 2023 | GBX2.55 Million | -6.85% |
| 2022 | GBX2.74 Million | -28.58% |
| 2021 | GBX3.84 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Life Science REIT PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.84 Million USD |
| MoneyControl | $1.84 Million USD |
| MarketWatch | $1.84 Million USD |
| marketcap.company | $1.84 Million USD |
| Reuters | $1.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.